Synovus Financial Corp Increases Position in The Cooper Companies, Inc. $COO

Key Points

• Synovus Financial Corp increased its stake in The Cooper Companies by 30.0%, acquiring an additional 9,609 shares, resulting in total holdings of 41,684 shares valued at $3,516,000.
• The Cooper Companies reported earnings of $0.96 per share for the latest quarter, surpassing analyst estimates of $0.93, with a revenue increase of 6.3% year-over-year.
• Recent analyst ratings on Cooper Companies show mixed opinions, with price targets adjusted downward, including a new "strong-buy" rating from BNP Paribas, and a consensus rating of "Moderate Buy".

Synovus Financial Corp raised its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 30.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,684 shares of the medical device company's stock after purchasing an additional 9,609 shares during the period. Synovus Financial Corp's holdings in Cooper Companies were worth $3,516,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Shell Asset Management Co. lifted its stake in Cooper Companies by 15.5% in the fourth quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock worth $87,000 after purchasing an additional 127 shares during the last quarter. UMB Bank n.a. lifted its stake in Cooper Companies by 16.7% in the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock worth $76,000 after purchasing an additional 129 shares during the last quarter. Horizon Investments LLC lifted its stake in Cooper Companies by 5.0% in the first quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock worth $241,000 after purchasing an additional 136 shares during the last quarter. Axxcess Wealth Management LLC lifted its stake in Cooper Companies by 1.9% in the first quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock worth $623,000 after purchasing an additional 140 shares during the last quarter. Finally, Mitchell & Pahl Private Wealth LLC lifted its stake in Cooper Companies by 1.8% in the first quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock worth $732,000 after purchasing an additional 157 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently commented on COO shares. Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research note on Tuesday, June 17th. Morgan Stanley set a $76.00 price objective on shares of Cooper Companies and gave the company an "equal weight" rating in a research note on Thursday. BNP Paribas raised shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 22nd. Wells Fargo & Company lowered their price objective on shares of Cooper Companies from $93.00 to $72.00 and set an "overweight" rating for the company in a research note on Thursday. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a research note on Thursday. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Cooper Companies presently has an average rating of "Moderate Buy" and a consensus price target of $86.64.

Cooper Companies Trading Up 4.4%

COO stock traded up $2.81 during trading on Friday, reaching $67.39. The company had a trading volume of 4,071,437 shares, compared to its average volume of 2,729,446. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $112.38. The company has a market cap of $13.40 billion, a P/E ratio of 33.20, a PEG ratio of 1.63 and a beta of 0.97. The business has a 50 day moving average of $72.29 and a 200 day moving average of $77.29. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the prior year, the firm earned $0.96 earnings per share. Cooper Companies's revenue was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.